Differential microRNAs expressions are associated with relapse and TP53 P.R377H mutation in pediatrics adrenocortical tumors (2012)
- Authors:
- USP affiliated authors: SCRIDELI, CARLOS ALBERTO - FMRP ; MARTINELLI JUNIOR, CARLOS EDUARDO - FMRP ; ANTONINI, SONIR ROBERTO RAUBER - FMRP ; CASTRO, MARGARET DE - FMRP ; TUCCI JUNIOR, SILVIO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- Subjects: CRIANÇAS; NEOPLASIAS DO CÓRTEX SUPRARRENAL; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Pediatric Blood & Cancer
- ISSN: 1545-5009
- Volume/Número/Paginação/Ano: v. 59, n. 6, p. 1070, res. PL005, 2012
- Conference titles: Congress of the International Society of Paediatric Oncology (SIOP)
-
ABNT
FEDATTO, Paola Fernanda et al. Differential microRNAs expressions are associated with relapse and TP53 P.R377H mutation in pediatrics adrenocortical tumors. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 25 jan. 2026. , 2012 -
APA
Fedatto, P. F., Oliveira, J. C. de, Lira, R. C. P., Tucci Júnior, S., Martinelli Junior, C. E., Antonini, S. R. R., et al. (2012). Differential microRNAs expressions are associated with relapse and TP53 P.R377H mutation in pediatrics adrenocortical tumors. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Fedatto PF, Oliveira JC de, Lira RCP, Tucci Júnior S, Martinelli Junior CE, Antonini SRR, Castro M de, Yunes JA, Mastellaro MJ, Brandalise SR, Tone LG, Scrideli CA. Differential microRNAs expressions are associated with relapse and TP53 P.R377H mutation in pediatrics adrenocortical tumors. Pediatric Blood & Cancer. 2012 ; 59( 6): 1070.[citado 2026 jan. 25 ] -
Vancouver
Fedatto PF, Oliveira JC de, Lira RCP, Tucci Júnior S, Martinelli Junior CE, Antonini SRR, Castro M de, Yunes JA, Mastellaro MJ, Brandalise SR, Tone LG, Scrideli CA. Differential microRNAs expressions are associated with relapse and TP53 P.R377H mutation in pediatrics adrenocortical tumors. Pediatric Blood & Cancer. 2012 ; 59( 6): 1070.[citado 2026 jan. 25 ] - AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line
- Overexpression of BCL2 and TNFA genes is associated with less aggressive disease in childhood adrenocortical tumors (ACT)
- Spindle checkpoint genes expression in childhood adrenocortical tumors (ACT): aurkb is associated with metastatic disease and poor survival
- microRNA signatures in pediatric adrenocortical tumors: identification of microRNAs and predicted pathways involved in tumorigenesis and prognosis
- Discriminating pediatric non-neoplastic adrenal tissue, metastatic and non-metastatic pediatric adrenocortical tumors by miRNA signatures
- WNT/beta-catenin pathway dysregulation in childhood adrenocortical tumors harboring the R337H p53 mutation
- High expression of miR-449 in childhood adrenocortical tumors seems to be due to a post-transcriptional event embedded in a tumor suppressive program governed by p53
- Altered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumours
- Pediatric and adult adrenocortical tumor display different patterns of SHH pathway expression
- Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): overexpression of aurora kinases A and B is associated with a poor prognosis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
